Clinical Trials Browser

Terminated × Hypersensitivity × ZD4054 × Clear all

NCT00929162 2012-08-07

ZD4054 (Zibotentan) or Placebo Plus Chemotherapy in Patients With Advanced Ovarian Cancer

Phase 2 Terminated

120 enrolled 8 charts

Hypersensitivity, Neoplasms